Dendreon's Provenge Therapeutic Cancer Vaccine Has A May 15 PDUFA Date
This article was originally published in The Pink Sheet Daily
Executive Summary
The prostate cancer immunotherapeutic is the first therapeutic cancer vaccine accepted for review by FDA.